Vedolizumab
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2200/2022-SML | 23. 12. 2022 | Alliance Healthcare s. r. o. | 25 332 640,96 | 23 029 673,60 | 25 332 640,96 | 23 029 673,60 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva zadavatele_Vedolizumab_EP.pdf | Písemná zpráva zadavatele | 11. 01. 2023 06:25 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Alliance Healthcare s. r. o. | Praha | 25 332 640,96 | 23 029 673,60 | CZK |
Price Actually Paid in Each Year of Performance
| 2200/2022-SML | 2023 | 5 918 205,32 | 5 380 186,65 |